WuXi Biologics (Cayman), Inc. (WXXWY)
13.65
+0.38
(+2.86%)
USD |
OTCM |
Sep 25, 16:00
WuXi Biologics Market Cap : 28.03B for Sept. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 25, 2026 | 28.03B |
| September 24, 2026 | 27.24B |
| September 23, 2026 | 27.37B |
| September 22, 2026 | 27.61B |
| September 21, 2026 | 28.29B |
| September 18, 2026 | 26.26B |
| September 17, 2026 | 26.36B |
| September 16, 2026 | 26.12B |
| September 15, 2026 | 25.98B |
| September 14, 2026 | 26.12B |
| September 11, 2026 | 24.88B |
| September 10, 2026 | 24.78B |
| September 09, 2026 | 25.27B |
| September 08, 2026 | 26.23B |
| September 04, 2026 | 26.00B |
| September 03, 2026 | 27.04B |
| September 02, 2026 | 26.25B |
| September 01, 2026 | 26.52B |
| August 31, 2026 | 25.77B |
| August 28, 2026 | 26.79B |
| August 27, 2026 | 26.60B |
| August 26, 2026 | 26.75B |
| August 25, 2026 | 26.46B |
| August 24, 2026 | 25.69B |
| August 21, 2026 | 26.75B |
| Date | Value |
|---|---|
| August 20, 2026 | 26.04B |
| August 19, 2026 | 25.46B |
| August 18, 2026 | 25.32B |
| August 17, 2026 | 24.33B |
| August 14, 2026 | 24.55B |
| August 13, 2026 | 23.89B |
| August 12, 2026 | 24.06B |
| August 11, 2026 | 24.14B |
| August 10, 2026 | 24.37B |
| August 07, 2026 | 24.08B |
| August 06, 2026 | 21.70B |
| August 05, 2026 | 21.00B |
| August 04, 2026 | 21.10B |
| August 03, 2026 | 20.46B |
| July 31, 2026 | 20.42B |
| July 30, 2026 | 20.05B |
| July 29, 2026 | 20.87B |
| July 28, 2026 | 20.28B |
| July 27, 2026 | 20.25B |
| July 24, 2026 | 20.44B |
| July 23, 2026 | 20.34B |
| July 22, 2026 | 20.48B |
| July 21, 2026 | 20.28B |
| July 20, 2026 | 20.21B |
| July 17, 2026 | 19.63B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Austar Lifesciences Ltd. | 10.25M |
| Agilent Technologies, Inc. | 48.72B |
| Bio-Rad Laboratories, Inc. | 10.19B |
| Bruker Corp. | 9.778B |
| Azenta, Inc. | 1.489B |
Market Cap Related Metrics
| PE Ratio | 40.03 |
| PS Ratio | 8.431 |
| PEG Ratio | 0.3828 |
| Price to Free Cash Flow | 45.29 |
| Price | 13.65 |
| Earnings Yield | 2.50% |
| PEGY Ratio | 0.3828 |
| Operating PE Ratio | 26.04 |
| Normalized PE Ratio | 42.64 |